| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 70 |
| 1 | TACROLIMUS | 65 |
| 2 | PREDNISONE | 60 |
| 3 | METHOTREXATE SODIUM | 59 |
| 4 | METHOTREXATE | 55 |
| 5 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 53 |
| 6 | TACROLIMUS OINTMENT 0.1% | 53 |
| 7 | MYCOPHENOLATE MOFETIL | 48 |
| 8 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 48 |
| 9 | PREDNISOLONE | 47 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PETROLATUM AND RESORCINOL | 1 | 0.1000 |
| 1 | ALVIMOPAN | 1 | 0.0217 |
| 2 | TRIMIPRAMINE MALEATE | 4 | 0.0101 |
| 3 | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | 1 | 0.0067 |
| 4 | ZONGERTINIB | 1 | 0.0060 |
| 5 | CEFTAZIDIME, AVIBACTAM | 1 | 0.0059 |
| 6 | SACROSIDASE | 1 | 0.0055 |
| 7 | COSYNTROPIN | 1 | 0.0045 |
| 8 | FAMCICLOVIR | 12 | 0.0043 |
| 9 | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS, POTASSIUM PHOSPHATE, MONOBASIC, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | 2 | 0.0043 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 161 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 60 |
| 2 | Kinase Inhibitor [EPC] | 56 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 55 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 46 |
| 5 | Alkylating Drug [EPC] | 44 |
| 6 | Benzodiazepine [EPC] | 44 |
| 7 | mTOR Inhibitor Immunosuppressant [EPC] | 42 |
| 8 | Proton Pump Inhibitor [EPC] | 36 |
| 9 | GLP-1 Receptor Agonist [EPC] | 33 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vasopressin Receptor Agonist [EPC] | 4 | 0.0121 |
| 1 | Sucrose-specific Enzyme [EPC] | 1 | 0.0055 |
| 2 | Ileal Bile Acid Transporter Inhibitor [EPC] | 1 | 0.0022 |
| 3 | Guanylate Cyclase-C Agonist [EPC] | 4 | 0.0019 |
| 4 | Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC] | 3 | 0.0017 |
| 5 | Asparagine-specific Enzyme [EPC] | 19 | 0.0014 |
| 6 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 26 | 0.0012 |
| 7 | Adrenocorticotropic Hormone [EPC] | 1 | 0.0011 |
| 8 | Macrolide Antibacterial [EPC] | 1 | 0.0010 |
| 9 | Surfactant [EPC] | 1 | 0.0009 |